The PE Ratio as of November 2024 (TTM) for PsyBio Therapeutics Corp. (PSYBF) is -0.25

According to PsyBio Therapeutics Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.25. This represents a change of -88.66% compared to the average of -2.20 of the last 4 quarters.

PsyBio Therapeutics Corp. (PSYBF) Historical PE Ratio (quarterly & annually)

How has PSYBF PE Ratio performed in the past?

The mean historical PE Ratio of PsyBio Therapeutics Corp. over the last ten years is -8.99. The current -0.25 PE Ratio has changed 178.03% with respect to the historical average. Over the past ten years (40 quarters), PSYBF's PE Ratio was at its highest in in the December 2022 quarter at -0.44. The PE Ratio was at its lowest in in the June 2020 quarter at -872.09.

PsyBio Therapeutics Corp. (PSYBF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of PsyBio Therapeutics Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PsyBio Therapeutics Corp. (PSYBF) Average PE Ratio

How has PSYBF PE Ratio performed in the past?

The current PE Ratio of PsyBio Therapeutics Corp. (PSYBF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

PsyBio Therapeutics Corp. (PSYBF) PE Ratio vs. Peers

How is PSYBF’s PE Ratio compared to its peers?

PsyBio Therapeutics Corp.’s PE Ratio is less than Health Sciences Group, Inc. (0), greater than VG Life Sciences Inc. (-20.33), greater than ZIVO Bioscience, Inc. (-4.36), less than MedMira Inc. (0), greater than Oxford Cannabinoid Technologies Holdings Plc (-17.94), greater than Neurobiological Technologies, Inc. (-0.51), less than Pharming Group N.V. (0), greater than Kane Biotech Inc. (-32.11), less than Nova Mentis Life Science Corp. (3.44), greater than Awakn Life Sciences Corp. (-1.81), greater than HAVN Life Sciences Inc. (-1.89), less than Tryp Therapeutics Inc. (0), greater than Mindset Pharma Inc. (-2.15), greater than Regenicin, Inc. (-13.41), less than AXIM Biotechnologies, Inc. (-0.03), greater than Biostage, Inc. (-0.35), greater than Wesana Health Holdings Inc. (-4.05), greater than null (-0.75),

Build a custom stock screener for PsyBio Therapeutics Corp. (PSYBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PsyBio Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PsyBio Therapeutics Corp. (PSYBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PsyBio Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.